These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1076 related items for PubMed ID: 6206157
21. Human newborn natural killer cell responses to activation by monoclonal antibodies. Effect of culture with herpes simplex virus. Hayward A, Laszlo M, Vafai A. J Immunol; 1989 Feb 15; 142(4):1139-43. PubMed ID: 2536766 [Abstract] [Full Text] [Related]
22. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. Yasukawa M, Zarling JM. J Immunol; 1984 Nov 15; 133(5):2736-42. PubMed ID: 6207243 [Abstract] [Full Text] [Related]
23. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. Holland TC, Marlin SD, Levine M, Glorioso J. J Virol; 1983 Feb 15; 45(2):672-82. PubMed ID: 6187935 [Abstract] [Full Text] [Related]
24. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro. Fitzgerald PA, Mendelsohn M, Lopez C. J Immunol; 1985 Apr 15; 134(4):2666-72. PubMed ID: 2982949 [Abstract] [Full Text] [Related]
25. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. Yasukawa M, Zarling JM. J Immunol; 1984 Jul 15; 133(1):422-7. PubMed ID: 6609990 [Abstract] [Full Text] [Related]
26. Role of interferon in natural kill of HSV-1-infected fibroblasts. Fitzgerald PA, von Wussow P, Lopez C. J Immunol; 1982 Aug 15; 129(2):819-23. PubMed ID: 6177785 [Abstract] [Full Text] [Related]
27. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection. Paya CV, Schoon RA, Leibson PJ. J Immunol; 1990 Jun 01; 144(11):4370-5. PubMed ID: 2160501 [Abstract] [Full Text] [Related]
28. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells. Burns GF, Triglia T, Werkmeister JA. J Immunol; 1984 Sep 01; 133(3):1656-63. PubMed ID: 6611374 [Abstract] [Full Text] [Related]
29. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage. Vargas-Cortes M, Hammarström ML, Hammarström S, Hellström U, Perlmann P. Eur J Immunol; 1986 Jul 01; 16(7):795-801. PubMed ID: 3522246 [Abstract] [Full Text] [Related]
30. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults. Chin TW, Plaeger-Marshall S, Ank BJ, Pressman SR, Stiehm ER. Nat Immun Cell Growth Regul; 1991 Jul 01; 10(5):237-46. PubMed ID: 1661847 [Abstract] [Full Text] [Related]
31. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells. Borysiewicz LK, Rodgers B, Morris S, Graham S, Sissons JG. J Immunol; 1985 Apr 01; 134(4):2695-701. PubMed ID: 2579152 [Abstract] [Full Text] [Related]
32. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. Schmidt RE, Bartley G, Levine H, Schlossman SF, Ritz J. J Immunol; 1985 Aug 01; 135(2):1020-5. PubMed ID: 3924996 [Abstract] [Full Text] [Related]
33. Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. Bishop GA, Kümel G, Schwartz SA, Glorioso JC. J Virol; 1986 Jan 01; 57(1):294-300. PubMed ID: 2416952 [Abstract] [Full Text] [Related]
34. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice. Tamesis RR, Rodriguez A, Hoang-Xuan T, Foster CS. Ger J Ophthalmol; 1993 Aug 01; 2(4-5):218-23. PubMed ID: 8220102 [Abstract] [Full Text] [Related]
35. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice. Tamesis RR, Foster CS. Invest Ophthalmol Vis Sci; 1990 Nov 01; 31(11):2224-9. PubMed ID: 1700771 [Abstract] [Full Text] [Related]
36. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo. Kohl S, Loo LS, Schmalstieg FS, Anderson DC. J Immunol; 1986 Sep 01; 137(5):1688-94. PubMed ID: 3528287 [Abstract] [Full Text] [Related]
37. Defective NK cell activity following thermal injury. Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD. Clin Exp Immunol; 1986 Nov 01; 66(2):384-92. PubMed ID: 3493101 [Abstract] [Full Text] [Related]
38. Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2. Bystrická M, Vancíková M, Kasalová M, Rajcáni J, Kostál M, Murányiová M, Poláková K, Russ G. Acta Virol; 1991 Apr 01; 35(2):152-64. PubMed ID: 1681713 [Abstract] [Full Text] [Related]
39. Activation of cloned human natural killer cells via Fc gamma RIII. Werfel T, Uciechowski P, Tetteroo PA, Kurrle R, Deicher H, Schmidt RE. J Immunol; 1989 Feb 15; 142(4):1102-6. PubMed ID: 2464637 [Abstract] [Full Text] [Related]
40. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity. Zarcone D, Tilden AB, Friedman HM, Grossi CE. Cancer Res; 1987 May 15; 47(10):2674-82. PubMed ID: 2436754 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]